Mass Balance Recovery, Metabolite Profile, and Metabolite Identification of [14C]-Paxalisib in Healthy Male Subjects
Clinical trial NCT05012670 · COMPLETED
Trial details
- NCT number
- NCT05012670
- Sponsor
- Kazia Therapeutics Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-18
- Primary completion
- 2023-03-30
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.